paxilline has been researched along with Rhabdomyosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, AE; Dehner, CA; Hirbe, AC; Shern, JF; Yohe, M | 1 |
| Avirneni-Vadlamudi, U; Cameron, S; Endicott, TR; Galindo, KA; Galindo, RL; Paulson, V | 1 |
1 review(s) available for paxilline and Rhabdomyosarcoma
| Article | Year |
|---|---|
Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.
Topics: Animals; Cell Line, Tumor; Epigenesis, Genetic; Gene Fusion; Humans; Mice; Models, Biological; Paxillin; Prognosis; Rhabdomyosarcoma; Signal Transduction | 2021 |
1 other study(ies) available for paxilline and Rhabdomyosarcoma
| Article | Year |
|---|---|
Drosophila and mammalian models uncover a role for the myoblast fusion gene TANC1 in rhabdomyosarcoma.
Topics: Animals; Cell Line, Tumor; Drosophila; Drosophila Proteins; Forkhead Transcription Factors; Gene Silencing; Genes, Insect; Humans; Lectins, C-Type; Membrane Fusion; Membrane Proteins; Mice; Muscle Proteins; Myoblasts, Skeletal; Oncogene Fusion; Oncogene Proteins, Fusion; Paxillin; Rats; Rhabdomyosarcoma | 2012 |